1. Home
  2. ATON vs EDSA Comparison

ATON vs EDSA Comparison

Compare ATON & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlphaTON Capital Corp.

ATON

AlphaTON Capital Corp.

N/A

Current Price

$0.33

Market Cap

9.3M

Sector

Energy

ML Signal

N/A

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$7.26

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATON
EDSA
Founded
1973
2015
Country
British Virgin Islands
Canada
Employees
4
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
7.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ATON
EDSA
Price
$0.33
$7.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$2.00
$5.00
AVG Volume (30 Days)
763.1K
315.9K
Earning Date
07-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.72
52 Week High
$13.80
$9.37

Technical Indicators

Market Signals
Indicator
ATON
EDSA
Relative Strength Index (RSI) 44.61 62.63
Support Level $0.28 $1.41
Resistance Level $0.35 $9.06
Average True Range (ATR) 0.03 0.73
MACD 0.01 -0.00
Stochastic Oscillator 71.54 83.74

Price Performance

Historical Comparison
ATON
EDSA

About ATON AlphaTON Capital Corp.

AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: